Cell study · hCMEC/D3 human cerebral endothelial cells

Thymosin beta-4 cut prion-driven leak in human brain endothelial cells

Checked against the paper Cell studyPublished by PepVault

The takeaway

Early cell evidence that thymosin beta-4 helped human brain endothelial cells keep their barrier when exposed to a prion fragment; it says nothing yet about effects in living animals or people.

Kind
Cell study
Studied in
HCMEC/D3 human cerebral endothelial cells
Published
2020
Journal
Eur J Pharmacol

What they tested

The team tested whether thymosin beta-4 (Tβ4) could protect human brain blood vessel cells from barrier damage caused by a prion protein fragment.

How the study was done

A lab study in a human cell line, hCMEC/D3 cerebral endothelial cells, used as a model of the blood-brain barrier, the wall that separates blood from the brain. The cells were exposed to PrP(106-126), a fragment of the prion protein, with and without Tβ4.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In hCMEC/D3 human cerebral endothelial cells, Tβ4 raised the amount of tight junction protein, the links that join these cells to each other. It also lowered the ratio of F-actin to G-actin, two forms of the cell's actin scaffold. Tβ4 significantly improved the leakiness, or vascular permeability dysfunction, caused by PrP(106-126). In the same cell model, PrP(106-126) on its own broke up tight junctions and disturbed the cell scaffold.

What it doesn’t show

This is work in a single cell line in a dish, not a result in animals or people. It used a prion protein fragment, not prion disease itself, and did not test whether Tβ4 changes the course of any brain disease.

The paper

Song et al. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction. Eur J Pharmacol. 2020.

The compounds

More studies on Thymosin Beta-4

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo